ID | Term | p-value |
---|---|---|
hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.51E-30 |
hsa05200 | Pathways in cancer | 1.46E-26 |
hsa05212 | Pancreatic cancer | 3.22E-20 |
hsa04210 | Apoptosis | 1.95E-19 |
hsa04932 | Non-alcoholic fatty liver disease | 1.05E-18 |
hsa05161 | Hepatitis B | 8.49E-18 |
hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 2.41E-17 |
hsa04931 | Insulin resistance | 2.78E-17 |
hsa05160 | Hepatitis C | 9.24E-17 |
hsa05215 | Prostate cancer | 9.57E-17 |
hsa05162 | Measles | 1.56E-16 |
hsa05210 | Colorectal cancer | 3.07E-16 |
hsa05163 | Human cytomegalovirus infection | 6.60E-16 |
hsa01521 | EGFR tyrosine kinase inhibitor resistance | 2.05E-15 |
hsa05206 | MicroRNAs in cancer | 2.57E-15 |
hsa04068 | FoxO signaling pathway | 1.80E-14 |
hsa04668 | TNF signaling pathway | 2.44E-14 |
hsa05418 | Fluid shear stress and atherosclerosis | 3.86E-14 |
hsa05164 | Influenza A | 1.16E-13 |
hsa04920 | Adipocytokine signaling pathway | 1.97E-13 |